6 participants
Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-01-10
- Start Date:
- 2009-08-31
- Completion:
- 2013-04-30
Conditions
- Primary Sclerosing Cholangitis
- Trisomy 7
- Cholangiocarcinoma
- Chemoprevention
Interventions
- DRUG
No Results Yet